Edaravone attenuates doxorubicin-induced oral mucosal injury via modulation of oxidative stress, inflammatory signaling, and the SIRT1/TLR4/NF-kB/ACE2 axis in rats

Mert Zeytinoglu, Aras Erdil, Sefa Çolak, Mustafa Sami Demirsoy, Ali Tuğrul Akin, Necla Değer, Derya Karabulut, Serdar Savaş Gül, Hatice Aygun, Oytun Erbaş · 2025

Read Edaravone attenuates doxorubicin-induced oral mucosal injury via modulation of oxidative stress, inflammatory signaling, and the SIRT1/TLR4/NF-kB/ACE2 axis in rats by Mert Zeytinoglu, Aras Erdil, Sefa Çolak, Mustafa Sami Demirsoy, Ali Tuğrul Akin, Necla Değer, Derya Karabulut, Serdar Savaş Gül, Hatice Aygun, Oytun Erbaş (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12659584.txt.

Description

BackgroundOral mucositis (OM) is a common complication of chemotherapy, particularly with anthracyclines like doxorubicin (DOX), which induce oxidative stress and inflammation. This study investigated the protective effects of edaravone (EDO), a free radical scavenger, against DOX-induced oral mucosal injury.MethodsTwenty-eight male Wistar rats were randomly divided into four groups (n = 7): Control, DOX (18 mg/kg, i.p.

Catalog record

CREATORMert Zeytinoglu, Aras Erdil, Sefa Çolak, Mustafa Sami Demirsoy, Ali Tuğrul Akin, Necla Değer, Derya Karabulut, Serdar Savaş Gül, Hatice Aygun, Oytun Erbaş
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12659584

Browse the full library · About the Tower of Babel